Table 2.
Effect of SMR (300 mg/kg) on serum alanine aminotransferase (ALT), aspartate amino transferase (AST), alkaline phosphatase (ALP) activities in paracetamol induced liver fibrosis in rat.
Groups | AST Median ± SD |
ALP Median ± SD |
ALT Median ± SD |
HCV | GSH Median ± SD |
TBARs Median ± SD |
---|---|---|---|---|---|---|
Control | 59.24 ± 1.89a | 206.89 ± 9.761a | 45.98 ± 2.35a | Negative | 0.535 ± 0.08a | 61.358 ± 21.22a |
Paracetamol | 206.33 ± 11.98b | 601 ± 18.25b | 122 ± 5.65b | Positive | 0.237 ± 0.06b | 11.128 ± 56.55b |
SMR + Paracetamol | 70.44 ± 7.84bc | 250 ± 11.97bc | 61.33 ± 4.78bc | Negative | 0.307 ± 0.10bc | 56.55 ± 15.78bc |
SMR + paracetamol + HG | 77.31 ± 13.5 cd | 258 ± 12.76 cd | 62.78 ± 2.03 cd | Negative | 0.389 ± 0.08 cd | 60.061 ± 12.49 cd |
Values expressed as mean ± SD (n = 6). Significant difference vs. a respective control, b respective paracetamol, c represented SMR, d respective diabetic groups, each at p < 0.05.